23andMe (ME) - 2024 Q4 - Earnings Call Transcript

23andMe Holding Co. (NASDAQ:ME) Q4 2024 Earnings Conference Call May 24, 2024 4:30 PM ET Company Participants Ian Cooney - Senior Director of Investor Relations Joe Selsavage - Chief Financial Officer and Chief Accounting Officer Anne Wojcicki - Chief Executive Officer and Co-Founder Jennifer Low - Head of Therapeutics Development Conference Call Participants David Lebowitz - Citi Steven Mah - TD Cowen Operator Hello, and welcome to 23andMe's Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results C ...